C. Rassekh
Papers
1
Total Citations
2
H-Index
1
About
Dr. C. Rassekh is a leading head and neck surgical oncologist whose work centers on de-intensification strategies for HPV-related oropharyngeal cancer, transoral robotic surgery (TORS), and personalized treatment approaches. Their most cited study, a Phase II trial published in 2022, demonstrated that volume and dose de-intensification following TORS and neck dissection can reduce treatment toxicity in p16+ oropharyngeal squamous cell carcinoma patients while maintaining excellent oncologic outcomes. With 2 citations already in a rapidly evolving field, this work is gaining traction as a paradigm-shifting approach to balancing cure rates with quality of life. Dr. Rassekh’s contributions are particularly notable for integrating surgical precision with radiation de-escalation, offering a roadmap for minimizing long-term side effects like dysphagia and xerostomia. Their research bridges the gap between aggressive multimodality therapy and functional preservation, making them a key voice in the movement toward less morbid, yet equally effective, treatments for HPV-driven head and neck cancers. For students and clinicians, Dr. Rassekh’s work exemplifies how surgical innovation can reshape standard-of-care protocols.
Research Focus
Key Achievements
Top Papers
- 1